Do you routinely recommend transition to dual PO antibiotic coverage for strep species and MRSA, for patients with purulent cellulitis and in the absence of culture data?
Do you routinely recommend transition to dual PO antibiotic coverage for strep species and MRSA, for patients with purulent cellulitis and in the absence of culture data?
Join Mednetto vote and see how they answered.
I use mostly Linezolid because:
- It’s now much cheaper.
- Even if on serotonin drugs, I can half the serotonin dose while they are on it.
- Covers pretty much all Strep and Staph, including MRSA.
- Protein synthesis inhibition may reduce toxins (like clinda in Strep fasciitis).
- There is no renal dose adju...
Join for free or sign in to see the full answer
I typically do cover both Strep and MRSA- Bactrim + 1st generation cephalosporin (e.g., Keflex or cefirdoxil) is a good combo. Single-drug options include Clindamycin and Doxycycline. Linezolid is also a good single-drug option.
Join for free or sign in to see the full answer
The Infectious Diseases Society of America recommends empiric MRSA coverage for non-purulent cellulitis when specific risk factors are present, including penetrating trauma, evidence of MRSA infection elsewhere, nasal colonization with MRSA, injection drug use, or systemic inflammatory response synd...
Join for free or sign in to see the full answer
I use linezolid for many of these scenarios. Cost Plus Drugs offers 30 tablets for about $26 as of today, yet patients may pay hundreds depending on their insurance and pharmacy. I discuss this with my patients and basically tell them to call me if the pharmacy charges them hundreds of dollars.
Sero...
Join for free or sign in to see the full answer